Assessment of late gadolinium enhancement in hypertrophic cardiomyopathy improves risk stratification based on current guidelines.
Wang J, Yang S, Ma X, Zhao K, Yang K, Yu S, Yin G, Dong Z, Song Y, Cui C, Li J, Wang C, Hao J, Lu M, Chen X, Zhao S.
Wang J, et al. Among authors: zhao k, zhao s.
Eur Heart J. 2023 Dec 1;44(45):4781-4792. doi: 10.1093/eurheartj/ehad581.
Eur Heart J. 2023.
PMID: 37795986